Revitope Oncology, Inc. Trademarks
Image Trademark

Image Trademark

Filed: December 23, 2020
Pharmaceuticals, namely, immunotherapies for the treatment of cancer and oncological conditions; oncological preparations…
Owned by: Revitope Oncology, Inc.
Serial Number: 90407633

Image Trademark

Image Trademark

Filed: December 23, 2020
Development of pharmaceutical preparations for the treatment of cancer; development of platform technology, namely, immunotherapy…
Owned by: Revitope Oncology, Inc.
Serial Number: 90407765

REVITOPE ONCOLOGY

REVITOPE ONCOLOGY

Filed: December 30, 2020
Development of pharmaceutical preparations for the treatment of cancer; development of platform technology, namely, immunotherapy…
Owned by: Revitope Oncology, Inc.
Serial Number: 90430409

REVITOPE ONCOLOGY

REVITOPE ONCOLOGY

Filed: December 30, 2020
Pharmaceuticals, namely, immunotherapies for the treatment of cancer and oncological conditions; oncological preparations…
Owned by: Revitope Oncology, Inc.
Serial Number: 90430529

ONEGATE

ONEGATE

Filed: January 15, 2021
Development of pharmaceutical preparations for the treatment of cancer; development of platform technology, namely, immunotherapy…
Owned by: Revitope Oncology, Inc.
Serial Number: 90468677

TWOGATE

TWOGATE

Filed: January 15, 2021
Development of pharmaceutical preparations for the treatment of cancer; development of platform technology, namely, immunotherapy…
Owned by: Revitope Oncology, Inc.
Serial Number: 90468693

AGATE

AGATE

Filed: January 15, 2021
Development of pharmaceutical preparations for the treatment of cancer; development of platform technology, namely, immunotherapy…
Owned by: Revitope Oncology, Inc.
Serial Number: 90468696

TGATE

TGATE

Filed: January 15, 2021
Development of pharmaceutical preparations for the treatment of cancer; development of platform technology, namely, immunotherapy…
Owned by: Revitope Oncology, Inc.
Serial Number: 90468753

PRECISIONGATE

PRECISIONGATE

Filed: January 21, 2021
Development of pharmaceutical preparations for the treatment of cancer; development of platform technology, namely, immunotherapy…
Owned by: Revitope Oncology, Inc.
Serial Number: 90479940